peoplePerson
Christophe Le Tourneau
Led SHIVA, the first randomised trial of genomics-matched therapy, and heads Institut Curie's early trials unit.
Christophe Le Tourneau led SHIVA, a randomised test of molecularly targeted therapy chosen by profiling, and directs early-phase trials at Institut Curie with a focus on head and neck cancer.
| Title | Journal | Year |
|---|---|---|
| Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA) | Lancet Oncology | 2015 |
Pages like this
not linked directly; found by shared links- InstitutionFondation ARC pour la recherche sur le cancer
Shares Institut Curie, UNICANCER.
- PersonCharu Aggarwal
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma.
- InstitutionInstitut National du Cancer
Shares Institut Curie, UNICANCER.
- InstitutionCentre Antoine Lacassagne
- InstitutionInstitut Bergonié
Shares UNICANCER, Comprehensive genomic profiling.
- InstitutionHaute Autorité de Santé
Shares Institut Curie, UNICANCER.
- InstitutionInstitut Pasteur
Shares Institut Curie, Head and neck squamous cell carcinoma.
- InstitutionInstitut Paoli-Calmettes
Shares UNICANCER, Comprehensive genomic profiling.